Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding



Status:Recruiting
Healthy:No
Age Range:18 - 50
Updated:3/13/2019
Start Date:October 1, 2018
End Date:February 1, 2021

Use our guide to learn which trials are right for you!

A Phase 3, Multicenter, Open-Label Study of a Levonorgestrel 52 mg Intrauterine System for the Treatment of Heavy Menstrual Bleeding

To assess the efficacy of a levonorgestrel 52 mg intrauterine system as a treatment for heavy
menstrual bleeding.

This study is a multicenter, open-label, evaluation of the efficacy and safety of LNG20 IUS
for treatment of heavy menstrual bleeding.

Inclusion Criteria:

- Reports subjectively heavy menses for most menses when not using hormonal
contraception or a copper IUD

- Healthy females 18-50 years old, inclusive, at the time of enrollment

- Typical menstrual cycle length of 21-35 days or less with variation from cycle to
cycle of typically 5 days of less

- Has menstrual blood loss in 2 or the 3 cycles during the screening phase with greater
than or equal to 80 mL per cycle as measured by the Alkaline Hematin Method

- Willing to use a medication other than a NSAID as first-line treatment for any pain
condition during the duration of study participation

- Willing to abstain from heterosexual intercourse or use acceptable contraception
during the screening phase; acceptable contraception includes male or female permanent
contraception, withdrawal (if has been used as current method prior to screening) or a
barrier method

Exclusion Criteria:

- Currently pregnant

- Planning to attempt to become pregnancy during the screening and treatment phases of
study participation (i.e., up to approximately 11 months after consent)

- Currently lactating or not having a subjectively heavy menses since discontinuation of
lactation prior to screening

- Clinical diagnosis of perimenopause (in the opinion of the investigator) based on one
or more of the following: changes in menstrual regularity (e.g., shorter, longer,
absent, irregular), hot flashes, sleeping disorder, or changes in mood (e.g.,
depression, nervous tension, and irritability) within 3 months prior to or during the
screening period

- Screening blood laboratory value outside of the normal range that, in the the opinion
of the investigator, requires treatment or further work-up (i.e., are considered
clinically significant)

- Has poor venous access or significant history of inability to have blood samples drawn

- History of bicornuate uterus or any other abnormality of the uterus resulting in
distortion of the uterine cavity or cervical canal incompatible with insertion

- Prior (documented within 6 months) or baseline study ultrasound examination
demonstrating:

1. a congenital or acquired uterine anomaly that distorts the uterine cavity or
cervical canal incompatible with insertion;

2. endometrial polyps (unless previously removed);

3. fibroids meeting any of the following criteria: i. distort the uterine cavity or
cervical canal incompatible with insertion; ii. submucosal location; iii.
exceeding 2 cm in the greatest dimension for any individual fibroid; iv. more
than three fibroids of a least 1.5 cm in greatest diameter

4. clear evidence of adenomyosis

- Chronic endometritis on endometrial biopsy at screening

- Has any of the following premalignant or malignant diseases:

1. malignant melanoma

2. acute malignancies affecting blood or leukemias

3. gestational trophoblastic disease (unless at least one year with undetectable
beta-hCG)

4. known or suspected cervical, ovarian, vaginal or vulvar cancer

5. uterine cancer or evidence of uterine malignancy, endometrial intraepithelial
neoplasia (EIN) or hyperplasia on an endometrial biopsy at screening (an
endometrial biopsy performed within 6 months of Visit 1 could be used if a report
is available with a tissue diagnosis)

6. history of breast cancer, or suspicion of breast cancer until proven otherwise

- Has any of the following medical conditions:

1. bleeding diathesis (inherited or acquired)

2. history of von Willebrand's disease or other known coagulopathy

3. uncontrolled significant hypertension defined as a sitting systolic blood
pressure greater than or equal to 160 mm Hg or diastolic blood pressure greater
than or equal to 95 mm Hg at any screening or enrollment visit

4. presence or history of venous thromboembolic diseases (deep vein thrombosis,
pulmonary embolism), presence or history of arterial thromboembolic diseases
(e.g., myocardial infarction, stroke)

5. uncontrolled thyroid disorder

6. sickle cell anemia

7. diabetes mellitus that is poorly controlled or with end-organ/vascular
complications

8. hyperprolactinemia at screening

9. acute or severe liver disease or liver tumor

10. history of or poorly controlled bipolar disorder, schizophrenia, psychosis, major
depressive disorder or other major psychiatric disorder according to the criteria
of the Diagnostic and Statistical Manual of Mental Disorders

11. history of a positive HIV test or having a partner who is known to be HIV
positive

- Use of antifibrinolytics, platelet aggregation inhibitors, anticoagulants or other
similar medications that can increase or decrease bleeding within 30 days prior to and
during the screening (EXCEPTION: NSAIDs can be used a second-line treatment for pain
management)

- Use of intrauterine or implantable contraception, progestin-only pills, combined
hormonal contraceptives or oral progestin therapy within 30 days before screening

- Depomedroxyprogesterone acetate (DMPA) injection within the past 9 months prior to
screening

- Use of non-contraceptive estrogen, progesterone, progestin, testosterone, androgen or
other gonadotropins (e.g. hCG) within 30 days before screening

- Prior total or partial endometrial ablation or resection

- History of a uterine aspiration or curettage procedure for any indication (other than
an office biopsy) within 4 weeks of screening
We found this trial at
21
sites
3451 Walnut St
Philadelphia, Pennsylvania 19104
1 (215) 898-5000
Phone: 215-349-5201
Univ of Pennsylvania Penn has a long and proud tradition of intellectual rigor and pursuit...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
1200 Moursund Street
Houston, Texas 77030
(713) 798-4951
Phone: 832-824-0403
Baylor College of Medicine Baylor College of Medicine in Houston, the only private medical school...
?
mi
from
Houston, TX
Click here to add this to my saved trials
3181 Southwest Sam Jackson Park Road
Portland, Oregon 97239
503 494-8311
Phone: 503-494-7051
Oregon Health and Science University In 1887, the inaugural class of the University of Oregon...
?
mi
from
Portland, OR
Click here to add this to my saved trials
201 Presidents Circle
Salt Lake City, Utah 84108
801) 581-7200
Phone: 801-213-2774
University of Utah Research is a major component in the life of the U benefiting...
?
mi
from
Salt Lake City, UT
Click here to add this to my saved trials
Ann Arbor, Michigan 48109
Phone: 734-647-1040
?
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Cincinnati, Ohio 45267
Phone: 513-584-4100
?
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Cleveland, Ohio 44012
Phone: 216-844-8091
?
mi
from
Cleveland, OH
Click here to add this to my saved trials
281 W. Lane Ave
Columbus, Ohio 43210
(614) 292-6446
Phone: 614-293-0075
Ohio State University The Ohio State University’s main Columbus campus is one of America’s largest...
?
mi
from
Columbus, OH
Click here to add this to my saved trials
Denver, Colorado 80291
Phone: 303-724-2013
?
mi
from
Denver, CO
Click here to add this to my saved trials
Idaho Falls, Idaho 83404
Phone: 208-270-6638
?
mi
from
Idaho Falls, ID
Click here to add this to my saved trials
Jacksonville, Florida 32207
Phone: 904-633-0772
?
mi
from
Jacksonville, FL
Click here to add this to my saved trials
Knoxville, Tennessee 37920
Phone: 865-305-7915
?
mi
from
Knoxville, TN
Click here to add this to my saved trials
Las Vegas, Nevada 89128
Phone: 702-242-8800
?
mi
from
Las Vegas, NV
Click here to add this to my saved trials
Lawrenceville, New Jersey 08648
Phone: 609-799-5010
?
mi
from
Lawrenceville, NJ
Click here to add this to my saved trials
1020 Walnut St
Philadelphia, Pennsylvania 19107
(215) 955-6000
Phone: 215-955-9243
Thomas Jefferson University We are dedicated to the health sciences and committed to educating professionals,...
?
mi
from
Philadelphia, PA
Click here to add this to my saved trials
Sacramento, California 95817
Phone: 916-734-6846
?
mi
from
Sacramento, CA
Click here to add this to my saved trials
Saint Louis, Missouri 63110
Phone: 314-747-1425
?
mi
from
Saint Louis, MO
Click here to add this to my saved trials
San Diego, California 92108
Phone: 619-521-2841
?
mi
from
San Diego, CA
Click here to add this to my saved trials
Scottsdale, Arizona 85251
Principal Investigator: Harris
Phone: 480-305-7423
?
mi
from
Scottsdale, AZ
Click here to add this to my saved trials
Stanford, California 94403
Phone: 650-721-1562
?
mi
from
Stanford, CA
Click here to add this to my saved trials
West Palm Beach, Florida 33409
Phone: 561-478-3177
?
mi
from
West Palm Beach, FL
Click here to add this to my saved trials